Albert Murtha

Contact Overview Publications

Contact

Faculty of Medicine & Dentistry - Oncology Dept

Email: amurtha@ualberta.ca
Phone: (780) 432-8517
Address: Cross Cancer Institute
11560 University Avenue

Edmonton AB

T6G 1Z2

Overview

Area of Study / Keywords

About

Clinical Interests
GU, neuro-oncology (Tumour Group Leader), Prostate Brachytherapy, Hematological Malignancies.

Research

Machine Learning (Artificial Intelligence) as Applied to the Treatment of Cancer.
Normal Tissue Tolerance to Radiation Therapy
High Field MRI and PET scanning for Prediction Tumour/Normal Tissue Response to Radiation Therapy
Low Dose Rate Radiobiology

Featured Publications

Conformal Plaque Brachytherapy Outcomes for Peripapillary Choroidal Melanoma

Canadian Ophthalmological Society. 2022 June;

Conformal Plaque Brachytherapy Outcomes for Peripapillary Choroidal Melanoma

International Society of Ocular Oncology. 2022 June;

Radiobiological Dose Evaluation for Uveal Melanoma Plaque Brachytherapy

Medical Physics. 2022 June; 10.1002/mp.15896

Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients with Newly Diagnosed High-grade Glioma

Wang M.H., Roa W., Wachowicz K., Yahya A., Murtha A., Amanie J., Chainey J., Quon H., Ghosh S., Patel S.

Anticancer Research. 2022 May; 42 (5):2665-2673 10.21873/anticanres.15744

Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)

Crook J., Rodgers J.P., Pisansky T.M., Trabulsi E.J., Amin M.B., Bice W., Morton G., Murtha A.D., Vigneault E., Helou J., Michalski J.M., Roach M., Beyer D., Jani A.B., Horwitz E.M., Raben A., Pugh S., Sandler H.

Int J Radiat Oncol Biol Phys. 2022 April; 112 (5):1115-1122 10.1016/j.ijrobp.2021.10.138

Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer

Wang M.H., Vos L.J., Yee D., Patel S., Pervez N., Parliament M., Usmani N., Danielson B., Amanie J., Pearcey R., Ghosh S., Field C., Fallone B.G., Murtha A.D.

Practical Radiation Oncology. 2022 March; 11 (5):384-393 10.1016/j.prro.2021.02.011

Plaque Brachytherapy Outcome for Large Choroidal Melanomas

Association for Research in Vision and Ophthalmology.. 2022 March;

A Randomized Trial of Short-Course Versus Conventional Radiotherapy with Concomitant and Adjuvant Temozolomide in Patients 18 to 70 Years of Age with Glioblastoma

International Journal of Radiation Oncology, Biology and Physics. 2021 November;

Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP Trial

International Journal of Radiation Oncology Biology Physics. 2021 October; 10.1016/j.ijrobp.2022.04.045

Ocular Brachytherapy for Intra-Ocular Melanoma: 5 Year Large Cohort Outcomes in the Province of Alberta

Radiotherapy and Oncology. 2021 October;

Predictors of Toxicity in a Randomized Study of Hypofractionated vs. Conventional Radiotherapy for Glioblastoma: Dosimetric Analysis of Organs at Risk

Radiotherapy and Oncology, 163 (Suppl1), S21.. 2021 October;

Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer

Wang M.H., Vos L.J., Yee D., Patel S., Pervez N., Parliament M., Usmani N., Danielson B., Amanie J., Pearcey R., Ghosh S., Field C., Fallone B.G., Murtha A.D.

Practical Radiation Oncology. 2021 March; 10.1016/j.prro.2021.02.011

Optimising Prediction of Early Metastasis-Free Survival in Uveal Melanoma Using a Four-category Model Incorporating Gene Expression Profile and Tumour Size

Roelofs K.A., Grewal P., Lapere S., Larocque M., Murtha A., Weis E.

BRITISH JOURNAL OF OPHTHALMOLOGY. 2020 December; 0 10.1136/bjophthalmol-2020-317714